B57206
3-Bromobenzaldehyde
97%
동의어(들):
3-Bromobenzaldehyde, 3-Formyl-1-bromobenzene, 3-Formylbromobenzene, 3-Formylphenyl bromide, 5-Bromobenzaldehyde, m-Bromobenzaldehyde, m-Formylphenyl bromide
로그인조직 및 계약 가격 보기
모든 사진(1)
About This Item
Linear Formula:
BrC6H4CHO
CAS Number:
Molecular Weight:
185.02
Beilstein:
1634534
EC Number:
MDL number:
UNSPSC 코드:
12352100
PubChem Substance ID:
NACRES:
NA.22
추천 제품
신호어
Warning
유해 및 위험 성명서
Hazard Classifications
Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
표적 기관
Respiratory system
Storage Class Code
10 - Combustible liquids
WGK
WGK 3
Flash Point (°F)
204.8 °F - closed cup
Flash Point (°C)
96 °C - closed cup
개인 보호 장비
Eyeshields, Faceshields, Gloves, type ABEK (EN14387) respirator filter
이미 열람한 고객
Duyang Gao et al.
Theranostics, 9(18), 5315-5331 (2019-08-15)
Background: Engineering a single organic-molecule-based nanoparticle integrating precise diagnosis and effective therapy is of great significance for cancer treatment and future clinical applications but remains a great challenge. The goal of this study is to explore small organic molecule-based nanoparticles
[Determination of 3-bromobenzaldehyde, 3-phenoxybenzaldehyde and 3-phenoxybenzyl alcohol in the air of the work place].
N Ia Smoliar
Gigiena i sanitariia, (2)(2), 69-69 (1990-02-01)
Antara Garai et al.
Chemistry (Weinheim an der Bergstrasse, Germany), 24(48), 12613-12622 (2018-06-09)
Metal- versus ligand-centered redox processes and the effects of substituents on the ligands on the spectroscopic properties of the metal complexes are at the heart of research on metal complexes with non-innocent ligands. This work presents three examples of chromium
J P Fernandez et al.
Journal of medicinal chemistry, 26(9), 1317-1319 (1983-09-01)
Molecular biotransformation of 2-phenylthiazolidine (1) and its m-bromo derivative (2) in the mouse is followed by autoradiographic studies and assessed by analysis of urinary metabolites. Cysteamine (4) is one of the metabolites of compounds 1 and 2. Radioprotective activity and
Subhasish Tapadar et al.
Bioorganic & medicinal chemistry, 23(24), 7543-7564 (2015-11-21)
Inhibition of the enzymatic activity of histone deacetylase (HDAC) is a promising therapeutic strategy for cancer treatment and several distinct small molecule histone deacetylase inhibitors (HDACi) have been reported. We have previously identified a new class of non-peptide macrocyclic HDACi
자사의 과학자팀은 생명 과학, 재료 과학, 화학 합성, 크로마토그래피, 분석 및 기타 많은 영역을 포함한 모든 과학 분야에 경험이 있습니다..
고객지원팀으로 연락바랍니다.